Vaccination against Smallpox in the Posteradication Era
Author(s) -
Louisa E. Chapman,
Gina T. Mootrey,
Linda J. Neff
Publication year - 2008
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1086/524379
Subject(s) - smallpox , medicine , vaccination , context (archaeology) , smallpox vaccine , virology , immunology , family medicine , intensive care medicine , vaccinia , paleontology , biochemistry , chemistry , gene , biology , recombinant dna
The following introduction describes the context in which the national smallpox vaccination program was implemented and highlights the significance of the key policy, programmatic, or scientific challenges, observations, and lessons learned that are presented in the articles that follow within this supplement to Clinical Infectious Diseases. Although the execution of this national program posed multiple complex and varied challenges, the focus of this supplement is on vaccine-associated adverse events and vaccine safety.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom